Inhibikase Therapeutics, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45719W2052
USD
1.51
0.1 (7.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryInhibikase Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
7.09%
0.3%
1W
-1.95%
0.54%
1M
-5.63%
-0.03%
YTD
-53.54%
16.46%
1Y
-46.07%
13.22%
3Y
163.02%
68.23%
5Y
%
86.81%
10Y
%
234.19%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.72%
0%
-12.72%
6 Months
-25.62%
0%
-25.62%
1 Year
-46.07%
0%
-46.07%
2 Years
63.38%
0%
63.38%
3 Years
163.02%
0%
163.02%
4 Years
-84.75%
0%
-84.75%
5 Years
0%
0%
0.0%

Inhibikase Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary